TaiGen Biopharmaceuticals Holdings Ltd (太景) on Thursday said that its hepatitis C drug, Furaprevir (TG-2349), has secured patent protection in the US until May 2037.
Apart from the US patent on Furaprevir’s solid dispersion formulation, the drug is protected by 98 patents in other major markets, the company said.
The US market for hepatitis C treatment is dominated by Gilead Sciences Inc’s offerings and becoming increasingly saturated, a TaiGen investor relations manager said.
Therefore, a US patent would be beneficial to the market value of TaiGen’s hepatitis C therapy, said the manager, who spoke on condition of anonymity.
Furaprevir, a NS3/4A protease inhibitor, is a component of a combination therapy being developed by a joint venture established by TaiGen and China’s HEC Pharma Co (東陽光藥), which supplies Yimitasvir (DAG-181), the NS 5 protein inhibitor that makes up the other half of the combination.
The combination therapy has begun phase 2 clinical trials in China and recruited about 80 percent of patients required for the study in about three months, the company said, adding that it would take two to three years to make the same progress in Taiwan.
Phase 2 clinical trials are expected to be completed before the end of this year, making TaiGen eligible for a US$5 million milestone payment from its Chinese partner, the company said.
The company plans to start phase 3 trials next year and expects to receive up to US$15 million in milestone payments between 2020 and 2021, it said.
TaiGen said its focus is still on China, where an estimated 10 million people could potentially be exposed to hepatitis C.
The Chinese market is anticipated to grow as local cities step up diagnostic and treatment efforts, the company said.
TaiGen shares have risen 0.23 percent this year, closing at NT$21.75 on Friday, lower than the biotech sub-index, which has gained 13.26 percent over the period.
CHIP WAR: Tariffs on Taiwanese chips would prompt companies to move their factories, but not necessarily to the US, unleashing a ‘global cross-sector tariff war’ US President Donald Trump would “shoot himself in the foot” if he follows through on his recent pledge to impose higher tariffs on Taiwanese and other foreign semiconductors entering the US, analysts said. Trump’s plans to raise tariffs on chips manufactured in Taiwan to as high as 100 percent would backfire, macroeconomist Henry Wu (吳嘉隆) said. He would “shoot himself in the foot,” Wu said on Saturday, as such economic measures would lead Taiwanese chip suppliers to pass on additional costs to their US clients and consumers, and ultimately cause another wave of inflation. Trump has claimed that Taiwan took up to
A start-up in Mexico is trying to help get a handle on one coastal city’s plastic waste problem by converting it into gasoline, diesel and other fuels. With less than 10 percent of the world’s plastics being recycled, Petgas’ idea is that rather than letting discarded plastic become waste, it can become productive again as fuel. Petgas developed a machine in the port city of Boca del Rio that uses pyrolysis, a thermodynamic process that heats plastics in the absence of oxygen, breaking it down to produce gasoline, diesel, kerosene, paraffin and coke. Petgas chief technology officer Carlos Parraguirre Diaz said that in
SUPPORT: The government said it would help firms deal with supply disruptions, after Trump signed orders imposing tariffs of 25 percent on imports from Canada and Mexico The government pledged to help companies with operations in Mexico, such as iPhone assembler Hon Hai Precision Industry Co (鴻海精密), also known as Foxconn Technology Group (富士康科技集團), shift production lines and investment if needed to deal with higher US tariffs. The Ministry of Economic Affairs yesterday announced measures to help local firms cope with the US tariff increases on Canada, Mexico, China and other potential areas. The ministry said that it would establish an investment and trade service center in the US to help Taiwanese firms assess the investment environment in different US states, plan supply chain relocation strategies and
Japan intends to closely monitor the impact on its currency of US President Donald Trump’s new tariffs and is worried about the international fallout from the trade imposts, Japanese Minister of Finance Katsunobu Kato said. “We need to carefully see how the exchange rate and other factors will be affected and what form US monetary policy will take in the future,” Kato said yesterday in an interview with Fuji Television. Japan is very concerned about how the tariffs might impact the global economy, he added. Kato spoke as nations and firms brace for potential repercussions after Trump unleashed the first salvo of
RSS